Which of the following statement is not true regarding dobutamine ?
**Core Concept:** Dobutamine is a synthetic catecholamine drug that mimics the effects of epinephrine and norepinephrine. It is used as a vasodilator, inotrope, and chronotrope to increase cardiac output and improve myocardial contractility in patients with cardiogenic shock or hypotension.
**Why the Correct Answer is Right:** Dobutamine is a selective beta-1 adrenergic agonist, which means it selectively binds to beta-1 receptors, leading to increased cardiac contractility and heart rate. It does not significantly affect beta-2 receptors, which prevents the side effects associated with non-selective beta-agonists like adrenaline.
**Why Each Wrong Option is Incorrect:**
A. This statement is incorrect because dobutamine does not cause bronchoconstriction due to its selective beta-1 receptor activation.
B. Although dobutamine can cause some degree of systemic vasodilation, it is not as potent as norepinephrine in this regard.
C. Dobutamine does increase heart rate, but the increase is moderate and selective, unlike adrenaline which can cause tachycardia and atrial fibrillation.
D. Dobutamine does not cause bronchospasm due to its selective beta-1 receptor activation, similar to option A.
**Why Dobutamine is Different from Adrenaline:**
Dobutamine is a synthetic drug designed to mimic the effects of endogenous catecholamines like epinephrine and norepinephrine. It has a much lower affinity for beta-2 receptors when compared to adrenaline, thus causing fewer side effects like bronchoconstriction and systemic vasoconstriction.
**Clinical Pearl:** Dobutamine is a safer alternative to adrenaline in patients with coronary artery disease because of its selective beta-1 receptor activation and reduced systemic and pulmonary vasoconstriction.
**Correct Answer:** D. Dobutamine does not cause bronchospasm due to its selective beta-1 receptor activation.